Kevin Michael O'Neill - Jul 31, 2023 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role: CEO, PDx
Signature: /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Stock symbol: GEHC
Transactions as of: Jul 31, 2023
Transactions value $: -$670,639
Form type: 4
Date filed: 8/2/2023, 04:05 PM
Previous filing: Mar 3, 2023
Next filing: Aug 7, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GEHC	Common Stock, par value $0.01 per share	Sale	-$179K	-2.33K	-8.85%	$76.55	24K	Jul 31, 2023	Direct	F1
transaction	GEHC	Common Stock, par value $0.01 per share	Options Exercise	$536K	+13.3K	+55.25%	$40.40	37.3K	Jul 31, 2023	Direct
transaction	GEHC	Common Stock, par value $0.01 per share	Sale	-$1.03M	-13.3K	-35.59%	$77.46	24K	Jul 31, 2023	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GEHC	Employee Stock Option (right to buy)	Options Exercise	$0	-13.3K	-100%	$0.00^*	0	Jul 31, 2023	Common Stock, par value $0.01 per share	13.3K	$40.40	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $76.55 to $76.59, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
F2	Includes sale of approximately 6,923 shares of GE HealthCare common stock to cover the exercise price of the stock options.
F3	The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $77.45 to $77.55, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).
F4	Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis, of which 100% are fully exercisable immediately.